Specific Clinical Experience Investigation for Long-term Use of Exenatide (Byetta Subcutaneous Injection)

Clinical trial NCT01817569 · COMPLETED

Trial details

NCT number: NCT01817569
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Type 2 Diabetes

Start date: 2011-02-13
Primary completion: 2019-10-03
Enrollment: 2948

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.